Restoring vision to millions of people - Biotech's Future

The video discusses retinal degenerative diseases like retinitis pigmentosa and macular degeneration, explaining how they affect vision. It introduces a retinal implant that uses light-activated proteins to restore vision by replacing lost photoreceptor cells. The implant is inserted subretinally and aims to help patients regain sight. Despite no current cure, the video highlights ongoing research and support from NSF and NIH to commercialize this technology, with hopes of market availability in 5-10 years. Challenges include ensuring the longevity of these chronic implants.

What is the initial effect of retinitis pigmentosa on vision?

• Improved night vision

• Complete blindness

• Loss of peripheral vision

• Loss of central vision

How does the retinal implant help restore vision?

• By replacing damaged rods and cones

• By absorbing light and directing ions to cells

• By improving blood flow to the retina

• By curing macular degeneration

What is the main challenge in developing retinal implants?

• Finding a cure for macular degeneration

• Increasing the size of the implants

• Reducing the cost of production

• Ensuring the implants are not removed daily

Which organizations are supporting the commercialization of the retinal implant?

• World Health Organization

• American Medical Association

• National Institutes of Health and NSF

• Centers for Disease Control and Prevention

What is the expected timeline for the retinal implant to reach the market?

• 1-2 years

• Over 10 years

• 3-4 years

• 5-10 years